Zimmer Biomet Holdings Inc. (ZBH): Price and Financial Metrics

Zimmer Biomet Holdings Inc. (ZBH): $126.43

-1.22 (-0.96%)

POWR Rating

Component Grades








Add ZBH to Watchlist
Sign Up

Industry: Medical - Devices & Equipment




#3 of 140

in industry

ZBH Price/Volume Stats

Current price $126.43 52-week high $149.25
Prev. close $127.65 52-week low $100.39
Day low $125.89 Volume 1,234,100
Day high $127.93 Avg. volume 1,387,181
50-day MA $132.86 Dividend yield 0.75%
200-day MA $121.73 Market Cap 26.37B

ZBH Stock Price Chart Interactive Chart >


  • ZBH scores best on the Growth dimension, with a Growth rank ahead of 98.22% of US stocks.
  • The strongest trend for ZBH is in Growth, which has been heading up over the past 179 days.
  • ZBH's current lowest rank is in the Stability metric (where it is better than 63.59% of US stocks).

ZBH Stock Summary

  • ZBH has a market capitalization of $26,826,181,437 -- more than approximately 92.01% of US stocks.
  • ZBH's current price/earnings ratio is 59.65, which is higher than 90.64% of US stocks with positive earnings.
  • In terms of twelve month growth in earnings before interest and taxes, ZIMMER BIOMET HOLDINGS INC is reporting a growth rate of 74.19%; that's higher than 84.36% of US stocks.
  • If you're looking for stocks that are quantitatively similar to ZIMMER BIOMET HOLDINGS INC, a group of peers worth examining would be PPG, BAX, WAB, HAS, and COO.
  • ZBH's SEC filings can be seen here. And to visit ZIMMER BIOMET HOLDINGS INC's official web site, go to www.zimmerbiomet.com.

ZBH Valuation Summary

  • ZBH's price/sales ratio is 3.8; this is 25.49% lower than that of the median Healthcare stock.
  • ZBH's price/sales ratio has moved down 2.5 over the prior 243 months.

Below are key valuation metrics over time for ZBH.

Stock Date P/S P/B P/E EV/EBIT
ZBH 2023-05-23 3.8 2.2 60.4 42.9
ZBH 2023-05-22 4.0 2.3 62.7 44.3
ZBH 2023-05-19 4.0 2.3 62.6 44.2
ZBH 2023-05-18 4.0 2.3 62.6 44.2
ZBH 2023-05-17 3.9 2.3 62.3 44.0
ZBH 2023-05-16 4.0 2.3 62.5 44.2

ZBH Growth Metrics

    The 2 year net cashflow from operations growth rate now stands at -15.01%.
  • Its 2 year cash and equivalents growth rate is now at -82.09%.
  • Its 4 year price growth rate is now at -0.56%.
ZBH's revenue has moved down $829,500,000 over the prior 33 months.

The table below shows ZBH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 7,152.7 1,406.2 277.9
2022-06-30 7,406.9 1,388.5 229.5
2022-03-31 7,652 1,489.9 217.7
2021-12-31 7,836.2 1,499.2 401.6
2021-09-30 7,883.6 1,558.6 819.3
2021-06-30 7,888.9 1,506.8 916.2

ZBH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ZBH has a Quality Grade of C, ranking ahead of 73.21% of graded US stocks.
  • ZBH's asset turnover comes in at 0.326 -- ranking 127th of 186 Medical Equipment stocks.
  • XRAY, NTUS, and TFX are the stocks whose asset turnover ratios are most correlated with ZBH.

The table below shows ZBH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.326 0.707 0.082
2021-03-31 0.295 0.696 0.051
2020-12-31 0.288 0.697 -0.005
2020-09-30 0.289 0.708 0.002
2020-06-30 0.287 0.711 -0.003
2020-03-31 0.316 0.719 0.028

ZBH Price Target

For more insight on analysts targets of ZBH, see our ZBH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $188.62 Average Broker Recommendation 1.42 (Moderate Buy)

Zimmer Biomet Holdings Inc. (ZBH) Company Bio

Zimmer Biomet is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. (Source:Wikipedia)

ZBH Latest News Stream

Event/Time News Detail
Loading, please wait...

ZBH Latest Social Stream

Loading social stream, please wait...

View Full ZBH Social Stream

Latest ZBH News From Around the Web

Below are the latest news stories about ZIMMER BIOMET HOLDINGS INC that investors may wish to consider to help them evaluate ZBH as an investment opportunity.

3 High-Reward Stocks Riding the Healthcare Boom

Healthcare stocks are a great option for long-term investors that want to ride out economic uncertainty and capitalize on the aging population.

Marie Brodbeck on InvestorPlace | May 22, 2023

The Returns At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Growing

There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...

Yahoo | May 22, 2023

Here's Why You Should Retain QIAGEN (QGEN) Stock for Now

QIAGEN (QGEN) is likely to benefit from high organic growth across its non-COVID-19 product group and portfolio advancements, reflecting a positive share price movement.

Yahoo | May 19, 2023

Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now

Myriad Genetics (MYGN) is likely to benefit from testing volumes across product segments and the latest partnerships, reflecting a positive share price movement.

Yahoo | May 18, 2023

Here's Why You Should Retain Charles River (CRL) Stock Now

Charles River's (CRL) share price is likely to grow, backed by strategic acquisitions and the DSA segment's strength.

Yahoo | May 17, 2023

Read More 'ZBH' Stories Here

ZBH Price Returns

1-mo -8.93%
3-mo 2.99%
6-mo 3.21%
1-year 6.05%
3-year 2.31%
5-year 16.66%
YTD -0.65%
2022 1.20%
2021 -17.02%
2020 3.77%
2019 45.37%
2018 -13.30%

ZBH Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full ZBH Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!